← Back to all trials
Recruiting
NCT07135453
Induction of Cross-protective Antibodies for Serogroup 33 by Pneumococcal Conjugate Vaccines
Conditions: Vaccine, Pneumococcal Disease
Sex: All
Ages: 18 Years – N/A
Healthy volunteers: Yes
Phase: PHASE4
Enrollment: 70
Sponsor: University of Alabama at Birmingham
Location: University of Alabama at Birmingham Birmingham Alabama
Summary
The goal of this study is to learn whether different types of vaccines to prevent bacterial infections are able to effectively create antibodies that defend against certain types of bacteria.
We will give two different types of vaccine and evaluate the effectiveness of antibodies produced by each vaccine in killing bacteria.
Eligibility Criteria
Inclusion Criteria:
* Healthy adult
Exclusion Criteria:
* No prior history of pneumococcal vaccination
* No immunosuppressing medications or chronic diseases that affect immune function
Source: ClinicalTrials.gov (NCT07135453). StuddyBuddy aggregates publicly available trial information.
